Skip to main content
. 2025 Aug 5;14(8):774. doi: 10.3390/pathogens14080774
ACE2 angiotensin-converting enzyme 2
Af-CAR Aspergillus fumigatus-specific chimeric antigen receptor
AIDS acquired immunodeficiency syndrome
allo-HCT allogeneic hematopoietic cell transplantation
ART antiretroviral therapy
BNAb broadly neutralizing antibody
CAR chimeric antigen receptor
cccDNA covalently closed circular DNA
CMV cytomegalovirus
COVID-19 Coronavirus disease-19
CRS cytokine release syndrome
CXCR5 C-X-C chemokine receptor type 5
D-CAR chimeric antigen receptor targeting Dectin-1 receptor
DNA deoxyribonucleic acid
E2 E2 glycoprotein
EBNA Epstein–Barr nuclear antigen
EBV Epstein–Barr virus
EGFRt truncated epidermal growth factor receptor
Fc crystallizable fragment
gp350 glycoprotein 350
gp120 glycoprotein 120
GXM glucuronoxylomannan
GXMR-CAR glucuronoxylomannan-specific chimeric antigen receptor
HBsAg hepatitis B surface antigen
HBV hepatitis B virus
HCV hepatitis C virus
HIV human immunodeficiency virus
HSV-TK herpes simplex virus thymidine kinase
iC9 inducible caspase 9
IFDs invasive fungal diseases
IFN-γ interferon-γ
IL-12 interleukin-12
IL-2 interleukin-2
IPA invasive pulmonary aspergillosis
L large surface proteins
LMP1 latent membrane protein 1
MERTK Mer tyrosine kinase
NK natural killer
PTLD post-transplant lymphoproliferative disease
RBD receptor-binding domain
RNA ribonucleic acid
S small surface proteins
S1 spike protein
scFv functional single-chain variable fragment
TCR T-cell receptor
TNF-a tumor necrosis factor-α
TRUCKs T cells capable of universal cytokine-mediated killing